Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes*

Background: Akt plays a major role in insulin regulation of metabolism. Results: Akt operates at 5–22% of its dynamic range. This lacks concordance with Akt substrate phosphorylation, GLUT4 translocation, and protein synthesis. Conclusion: Akt is a demultiplexer that splits the insulin signal into discrete outputs. Significance: This study provides better understanding of the Akt pathway and has implications for the role of Akt in diseases. Akt plays a major role in insulin regulation of metabolism in muscle, fat, and liver. Here, we show that in 3T3-L1 adipocytes, Akt operates optimally over a limited dynamic range. This indicates that Akt is a highly sensitive amplification step in the pathway. With robust insulin stimulation, substantial changes in Akt phosphorylation using either pharmacologic or genetic manipulations had relatively little effect on Akt activity. By integrating these data we observed that half-maximal Akt activity was achieved at a threshold level of Akt phosphorylation corresponding to 5–22% of its full dynamic range. This behavior was also associated with lack of concordance or demultiplexing in the behavior of downstream components. Most notably, FoxO1 phosphorylation was more sensitive to insulin and did not exhibit a change in its rate of phosphorylation between 1 and 100 nm insulin compared with other substrates (AS160, TSC2, GSK3). Similar differences were observed between various insulin-regulated pathways such as GLUT4 translocation and protein synthesis. These data indicate that Akt itself is a major amplification switch in the insulin signaling pathway and that features of the pathway enable the insulin signal to be split or demultiplexed into discrete outputs. This has important implications for the role of this pathway in disease.

[1]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[2]  T. Haruta,et al.  Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin , 2001, Molecular and Cellular Biology.

[3]  G. Sethi,et al.  Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice , 2011, Journal of Molecular Medicine.

[4]  B. Manning,et al.  A complex interplay between Akt, TSC2 and the two mTOR complexes. , 2009, Biochemical Society transactions.

[5]  L. Cantley,et al.  Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions* , 2003, Journal of Biological Chemistry.

[6]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[7]  Kenneth C. Anderson,et al.  Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma , 2010, Molecular Cancer Therapeutics.

[8]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[9]  D. James,et al.  Cluster Analysis of Insulin Action in Adipocytes Reveals a Key Role for Akt at the Plasma Membrane* , 2009, The Journal of Biological Chemistry.

[10]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[11]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[12]  Q. Boese,et al.  Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  John M Asara,et al.  Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.

[14]  D. Mak,et al.  Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Koshland,et al.  Amplification and adaptation in regulatory and sensory systems. , 1982, Science.

[16]  D. James,et al.  Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes. , 2011, The Biochemical journal.

[17]  香留 崇 Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions , 2004 .

[18]  J. Asara,et al.  Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.

[19]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[20]  C. Lang,et al.  PRAS40 Regulates Protein Synthesis and Cell Cycle in C2C12 Myoblasts , 2010, Molecular medicine.

[21]  J. Ferrell,et al.  Interlinked Fast and Slow Positive Feedback Loops Drive Reliable Cell Decisions , 2005, Science.

[22]  C. W. Garner,et al.  Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. , 1993, Biochemical and biophysical research communications.

[23]  Don-On Daniel Mak,et al.  Inositol 1,4,5-tris-phosphate activation of inositol tris-phosphate receptor Ca2+ channel by ligand tuning of Ca2+ inhibition , 1998 .

[24]  B. Hemmings,et al.  Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies , 2006, Molecular and Cellular Biology.

[25]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[26]  C. Kahn Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. , 1978, Metabolism: clinical and experimental.

[27]  D. James,et al.  Characterization of Munc-18c and Syntaxin-4 in 3T3-L1 Adipocytes , 1997, The Journal of Biological Chemistry.

[28]  D. James,et al.  Akt inhibitors reduce glucose uptake independently of their effects on Akt. , 2010, The Biochemical journal.

[29]  A. Marette,et al.  Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. , 2005, Endocrinology.

[30]  David E James,et al.  Characterization of the Role of the Rab GTPase-activating Protein AS160 in Insulin-regulated GLUT4 Trafficking* , 2005, Journal of Biological Chemistry.

[31]  P. Cohen,et al.  Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. , 1999, The Biochemical journal.

[32]  R. Roth,et al.  PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.

[33]  T. McGraw,et al.  The Akt kinases: Isoform specificity in metabolism and cancer , 2009, Cell cycle.

[34]  Alexandros Tzatsos,et al.  Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation , 2006, Molecular and Cellular Biology.

[35]  B. Jacobson,et al.  Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. , 1983, The Journal of biological chemistry.

[36]  D. James,et al.  Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. , 2008, Cell metabolism.

[37]  K. Okkenhaug,et al.  Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation , 2006, Nature.

[38]  T. McGraw,et al.  Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling , 2009, Proceedings of the National Academy of Sciences.

[39]  D. James,et al.  The Role of Ca2+ in Insulin-stimulated Glucose Transport in 3T3-L1 Cells* , 2001, The Journal of Biological Chemistry.

[40]  M. Birnbaum,et al.  Role of Akt/protein kinase B in metabolism , 2002, Trends in Endocrinology & Metabolism.

[41]  David E James,et al.  IRS1-independent defects define major nodes of insulin resistance. , 2008, Cell metabolism.

[42]  D. Alessi,et al.  The role of PI 3-kinase in insulin action. , 1998, Biochimica et biophysica acta.

[43]  C. Lang,et al.  PRAS40 Regulates Protein Synthesis and Cell Cycle in C2C12 , 2022 .

[44]  J. Olefsky,et al.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.

[45]  C. Lindsley,et al.  Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. , 2005, Molecular cancer therapeutics.

[46]  D. James,et al.  Insulin Increases Cell Surface GLUT4 Levels by Dose Dependently Discharging GLUT4 into a Cell Surface Recycling Pathway , 2004, Molecular and Cellular Biology.

[47]  U. Tatu,et al.  Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype , 2009, Systems and Synthetic Biology.